Evaluation of Safety and Exploratory Efficacy of an Autologous Adipose-derived Cell Therapy Product for Treatment of Single Knee Osteoarthritis
Public ClinicalTrials.gov record NCT04043819. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of Safety and Exploratory Efficacy of PSC-01, an Autologous Adipose-derived Stromal Vascular Fraction Cell Therapy Product for the Treatment of Knee Osteoarthritis
Study identification
- NCT ID
- NCT04043819
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Personalized Stem Cells, Inc.
- Industry
- Enrollment
- 125 participants
Conditions and interventions
Conditions
Interventions
- PSC-01 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 6, 2019
- Primary completion
- Dec 31, 2020
- Completion
- Dec 31, 2020
- Last update posted
- Sep 15, 2020
2019 – 2021
United States locations
- U.S. sites
- 7
- U.S. states
- 4
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| San Diego Orthobiologics Medical Group | Carlsbad | California | 92011 | — |
| Grossmont Orthopedic Medical Group | La Mesa | California | 91942 | — |
| Synergy Orthopedic Specialists Medical Group | San Diego | California | 92121 | — |
| The Orthohealing Center | Santa Monica | California | 90025 | — |
| Cellular Orthopedics | Des Plaines | Illinois | 60016 | — |
| New Jersey Regenerative Institute | Cedar Knolls | New Jersey | 07927 | — |
| RestorePDX | Beaverton | Oregon | 97008 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04043819, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 15, 2020 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04043819 live on ClinicalTrials.gov.